George Yancopoulos
President and Chief Scientific at Regeneron Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Regeneron Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Regeneron Pharmaceuticals Inc. June 13, 202596.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 31, 2025 | Regeneron Pharmaceuticals Inc. | Option exercise | +28,570 | — | — |
| Dec 31, 2025 | Regeneron Pharmaceuticals Inc. | Shares withheld for tax | −28,570 | $772.09 | $22,058,611 |
| Dec 9, 2025 | Regeneron Pharmaceuticals Inc. | Option exercise | +146,815 | $555.67 | $81,580,691 |
| Dec 9, 2025 | Regeneron Pharmaceuticals Inc. | Shares withheld for tax | −131,874 | $701.51 | $92,510,930 |
| Jun 10, 2024 | Regeneron Pharmaceuticals Inc. | Gift | −75,799 | — | — |
| Jun 10, 2024 | Regeneron Pharmaceuticals Inc. | Gift | +37,900 | — | — |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −907 | $967.40 | $877,432 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −3,213 | $968.44 | $3,111,598 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −9,501 | $969.39 | $9,210,174 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −4,669 | $970.26 | $4,530,144 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −4,922 | $971.56 | $4,782,018 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −790 | $972.22 | $768,054 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −2,653 | $973.80 | $2,583,491 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −7,611 | $974.51 | $7,416,996 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −9,242 | $975.48 | $9,015,386 |
Questions about George Yancopoulos
What boards is George Yancopoulos on?
George Yancopoulos sits on the board of Regeneron Pharmaceuticals Inc.
How long has George Yancopoulos served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.